Marty Sutter is a Co-Founder of the Firm, and dedicated his career to making successful growth equity and venture capital investments in healthcare companies. Educated in chemical engineering and finance, he has more than 30 years of management experience in operations, marketing, finance and venture capital.
Marty founded and managed The Woodlands Venture Capital Company, a wholly-owned subsidiary of Mitchell Energy & Development Corporation, and The Woodlands Venture Partners, an independent venture capital partnership. During his tenure with both organizations, he founded a number of successful healthcare companies originating from various institutions of the world renowned Texas Medical Center. As a consequence of numerous co-investments with Jim Currie, Marty merged his venture practice with Essex Venture Partners, founded by Jim Currie, to form Essex Woodlands Health Ventures in 1985.
Marty has been directly involved with more than 30 Essex Woodlands portfolio investments, and has served on numerous Boards of Directors of public and private companies including portfolio companies ATS Medical (acquired by Medtronic), BioForm Medical (acquired by Merz GmbH), LifeCell (acquired by Kinetic Concepts), St. Francis Medical (acquired by Kyphon [Medtronic]), Confluent Surgical (acquired by Tyco [Covidien]) and Rinat Neurosciences (acquired by Pfizer). Mr. Sutter currently serves on the Board of Directors of Abiomed, QSpex Technologies, Bioventus, Prolacta and Xenex. In addition to the portfolio company boards on which he serves, Marty is a past Chairman of the Texas Lyceum Association, and was formerly a Trustee of the Culinary Institute of America.
Marty holds a Bachelor of Science degree from Louisiana State University and a Master of Business Administration degree from the University of Houston. He is an avid and competitive yachtsman, and enjoys all forms of watersports.